Company · GMED
Globus Medical, Inc.
Name as listed on its exchange; filed with the SEC as GLOBUS MEDICAL INC.
Nasdaq's symbol directory lists GMED on the New York Stock Exchange as “Globus Medical, Inc. Class A Common Stock”.
In the 12 months to Nov 19, 2026: insiders sold on 4 occasions ($8.0M); 3 planned-sale notices; 2 filings by holders of 5% or more; 3 congressional trade disclosures; 1 company report (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- TOBIN JAMES R sold $5.4M
- ZARRILLI STEPHEN T sold $2.2M
- RHOADS ANN D sold $425K
Every trade (4)
- SELLTOBIN JAMES R sold $3.1M
- SELLRHOADS ANN D sold $425K
- SELLTOBIN JAMES R sold $2.2M
- SELLZARRILLI STEPHEN T sold $2.2M
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- TOBIN JAMES R $3.1M
- RHOADS ANN D $425K
- TOBIN JAMES R $2.2M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Vanguard Capital Management 4.43%
- BlackRock, Inc. 8%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $15,001 - $50,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition; Other events Nov 5, 2026
Lobbying · Senate LDA reports
Lobbying filed
2 quarterly lobbying reports for 2026 naming Globus Medical, Inc. as the client: 2 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- BALLARD SPAHR LLP no amount stated
- BALLARD SPAHR LLP no amount stated
Federal contracts · USAspending.gov
Federal contracts
55 contract awards first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $561K in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.
- Department of Defense $61K
- Department of Defense $42K
- Department of Defense $33K
- Department of Defense $27K
- Department of Defense $24K
- Department of Defense $21K
- Department of Defense $18K
- Department of Defense $17K
- Department of Defense $17K
- Department of Defense $16K
- Department of Defense $15K
- Department of Defense $15K
- Department of Defense $15K
- Department of Defense $15K
- Department of Defense $15K
- Department of Defense $14K
- Department of Defense $13K
- Department of Defense $12K
- Department of Defense $11K
- Department of Defense $10K
- Department of Defense $10K
- Department of Defense $10K
- Department of Defense $10K
- Department of Defense $10K
- Department of Defense $9K
Showing the 25 largest of 55.
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, USAspending.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.